title: Inhibition of morphine metabolism by ketamine.
abstract: Clinical observation of a synergistic effect of ketamine on morphine analgesia remains controversial. Although a pharmacodynamic basis for an interaction has been explored in animal and clinical studies, the possibility of a pharmacokinetic mechanism has not been investigated. Whereas both morphine and morphine-6-glucuronide are effective analgesics, morphine-3-glucuronide (M3G) lacks activity. Thus, changes in the metabolism and disposition of morphine may result in an altered response. First, we investigated the interaction between morphine and ketamine in the isolated perfused rat liver preparation. The clearance of morphine was decreased from 16.8 +/- 4.6 ml/min in the control period to 7.7 +/- 2.8 ml/min in the ketamine-treatment period, with the formation clearance of M3G decreasing from 8.0 +/- 4.1 ml/min to 2.1 +/- 1.1 ml/min. Fractional conversion of morphine to M3G was significantly decreased from 0.46 +/- 0.17 in the control period to 0.28 +/- 0.14 upon the addition of ketamine. The possible mechanism of the interaction was further investigated in vitro with rat liver microsomes as the enzyme source. The formation of M3G followed single-enzyme Michaelis-Menten kinetics, with a mean apparent K(m) of 2.18 +/- 0.45 mM and V(max) of 8.67 +/- 0.59 nmol/min/mg. Ketamine inhibited morphine 3-glucuronidation noncompetitively, with a mean K(i) value of 33.3 +/- 7.9 microM. The results demonstrate that ketamine inhibits the glucuronidation of morphine in a rat model.
authors.affiliation: School of Pharmacy and Medical Sciences, University of South Australia, North Terrace, Adelaide SA 5000, Australia.
authors.forename: Xiaoxin
authors.initials: X
authors.lastname: Qi
authors.forename: Allan M
authors.initials: AM
authors.lastname: Evans
authors.forename: Jiping
authors.initials: J
authors.lastname: Wang
authors.forename: John O
authors.initials: JO
authors.lastname: Miners
authors.forename: Richard N
authors.initials: RN
authors.lastname: Upton
authors.forename: Robert W
authors.initials: RW
authors.lastname: Milne
mesh_terms: D000818:Animals; D001646:Bile / Q000378:metabolism; D055162:Biocatalysis; D004347:Drug Interactions; D014453:Glucuronosyltransferase / Q000037:antagonists & inhibitors; D007649:Ketamine / Q000494:pharmacology*; D007700:Kinetics; D008099:Liver / Q000187:drug effects / Q000201:enzymology; D008297:Male; D008660:Metabolism / Q000187:drug effects*; D008862:Microsomes, Liver / Q000187:drug effects / Q000201:enzymology; D009020:Morphine / Q000378:metabolism* / Q000493:pharmacokinetics; D009022:Morphine Derivatives / Q000378:metabolism; D010477:Perfusion; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D009022:Morphine Derivatives; D007649:Ketamine; D009020:Morphine; D014453:Glucuronosyltransferase; C018108:morphine-3-glucuronide